A double blind study of intranasal calcitonin for established postmenopausal osteoporosis

Acta Orthopaedica Scandinavica, Supplement

Volumn 68, Issue 275, 1997, Pages 108-111

  Kapetanos, George ^a,b   Symeonides, Panayotis P ^a   Dimitriou, Christos ^a   Karakatsanis, Konstantin ^a   Potoupnis, Michael ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; HYDROXYPROLINE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MINERAL; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CERVICAL SPINE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CREATININE URINE LEVEL; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HUMAN; HYDROXYPROLINE URINE LEVEL; INTRANASAL DRUG ADMINISTRATION; POSTMENOPAUSE OSTEOPOROSIS; SPINE; VERTEBRA FRACTURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; MIDDLE AGED; OSTEOLYSIS; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRANASAL; AGED; BONE DENSITY; BONE RESORPTION; CALCITONIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0031253057     PISSN: 03008827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Azria M. The Calcitonins. Karger, Basel 1989.
2. Boerlin V, Nuesch E, Schmid AC, Sembler J. Bioavailability study with Salmon Calcitonin in man (Intramuscular injection vs intranasal administration) Sandoz LTD, Pharmaceutial Div. Research and Development. Basel 1983.
3. Chambers TJ, Moore A. The Sensitivity of isolated osteoclasts to morphological transformation by calcitonin. Clin Endocrinol 1983; 57: 819-24.
4. Christiansen C, Riis BJ. The Silent Epidemic. Postmenopausal Osteoporosis. National Osteoporosis Society and European Foundation for Osteoporosis and Bone Disease. Aslborg, Denmark 1990.
5. Gennari C, Montagnani M, Nardi P, Zacchei F, Bigazzi S, Cepollaro C. Long term effect of cyclic or continous calcitonin treatment on bone mass in established postmenopausal osteoporosis. In: Osteoporosis 1987 (Eds. Christiansen C, Johansen JS, Riis BJ.) Osteopress ApS, Kopenhavn, Denmark 1987: 919-21.
6. Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut III CH. Long term calcitonin therapy in postmenopausal osteoporosis. Metabolism 1984; 33: 295-303.
7. Franceschini R, Bottaro P, Panopoulos C, Messina V. Long term treatment with salmon calcitonin in post menopausal osteoporosis. Current Therapeutic Res Clinical and Experimental 1983; 34: 795-800.
8. Kapetanos G, Marougiannis J, Symeonides P. The postmenopausal osteoporosis treatment. In: Proceedings of the Second International Conference on Osteoporosis. Athens, Greece 1985 1986; 361-70.
9. Kapetanos G, Dimitriou C, Samara V, Siountas A, Symeonides P. Metabolic and Bone effects of cyclical administration of Salmon Calcitonin in osteoporosis. (Abstract) Eur J Clin Invest 1989; 19: 508.
10. Mazzuoli GF, Passeri M, Gennari C, Minisola S, Antonelli E, Valtorta C, Rallumer E, Cervelllin GF, Conneli S, Fracini G. Effects of Salmon calcitonin in postmenopausal osteoporosis. A controlled double-blind study. Calcif Tissue Int 1986; 38: 3-8.
11. Melton LJ, Riggs BL. Epidemiology of age related fractures in osteoporotic syndrome Grune and Stratton, Inc. (Orlando Florida 1987.
12. Overgaard K, Riis BJ, Christiansen C, Podenphant J, Johansen JS. Nasal Calcitonin for treatment of established osteoporosis. Clin Endocr 1989; 30: 435-42.
13. Overgaard K, Christiansen C. Long term treatment of established osteoporosis with intranasal calcitonin. Calsif Tissue Int 1991; 49: 60-3.
14. Overgaard K, Hansen M, Jensen SB, Christiansen C. Effect of Salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. Br Med J. 1992; 305: 556-61.
15. Reginster JY, Denis D, Albert A, Devoisy R, Lecart MP, Fontaine MA, Lambelin P, Franchimount P. One year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 1987; ii: 1481-3.
16. Riis BJ, Christiansen C, Overgaard K. The effect of nasal calcitonin on postmenopausal osteoporosis. In: New horizons in osteoporosis. (Ed. Christiansen C) Parthenon Publ. Group, Lanes UK 1988.